SCU WestChina-Lung Knight

Our problem

According to statistics, more than 3 million people worldwide suffer from pulmonary fibrosis(PF).

Our inspiration

We really hope to build a screening platform for anti-pulmonary fibrosis polypeptide drugs. We have innovatively put forward that using peptide drugs together to block signaling pathways and activate collagen degradation reactions to rebuild the balance of normal repair.

Our goal

And in this case, we can pick up the best soldiers to block and reverse the pulmanory fibrosis, And we believe that we can bring new ideas for organ and tissue fibrosis.